France Launched in 2022 under the France 2030 biocluster programme, the Paris-Saclay Cancer Cluster (PSCC) is rapidly positioning itself as a new epicentre for oncology innovation in Europe. Under the leadership of CEO Benjamin Garel, it brings together world-class hospitals, leading universities, and major pharmaceutical partners with the mission of transforming…
See our Cookie Privacy Policy Here
